Mechanisms of Renoprotection by Relaxin in Hypertension
Mechanisms of Renoprotection by Relaxin in Hypertension
批准号:
8690044
负责人:
Jennifer M Sasser
金额:
$12.68万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-06-30
关键词:
AddressAdverse effectsAffectAgonistAngiotensin IIAntihypertensive AgentsAntioxidantsBasic ScienceBiological AvailabilityBlood PressureChronicChronic Kidney FailureClinical DataClinical SciencesCost of IllnessDataDiseaseEnd stage renal failureEndothelinEndothelin B ReceptorEndothelin-1EnvironmentEnzymesExperimental ModelsFloridaFoundationsGoalsHealthHypertensionHypotensionIncidenceInjuryKidneyKidney DiseasesKnowledgeMeasuresMediatingMentorsMolecularNitric OxideNitric Oxide PathwayNitric Oxide SynthaseOrganOxidative StressPatientsPeptidesPharmacologic ActionsPhosphorylationPhysiologyPreventionPropertyRattusReactive Oxygen SpeciesRegulationRelaxinRenal functionResearchResearch PersonnelRoleSystemTestingTherapeuticTraining ProgramsUniversitiesUp-RegulationWorkbasecareercareer developmentcostdesignfunctional genomicsgene therapyhemodynamicshypertension treatmentimprovedinhibitor/antagonistinterestnovelnovel therapeutic interventionpeptide hormonepreventprogramsreceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent studies indicate that the peptide hormone relaxin has multiple beneficial actions in the cardio-renal system under pathological conditions due to its vasodilatory, anti-fibrotic, and angiogenic properties. Therefore, relaxin holds great promise as a novel therapeutic intervention for patients with kidney disease. The tremendous therapeutic potential of relaxin in hypertension induced chronic kidney disease can only be determined by first carefully investigating the actions of this peptide in experimental models of disease. This proposal will determine the molecular mechanisms of the renoprotective actions of relaxin during hypertension by testing the hypothesis that relaxin stimulates the endothelin B receptor - nitric oxide pathway to lower blood pressure and prevent progression of renal injury in hypertensive rats. Proposed studies will also investigate the potential for relaxin gene therapy in
the treatment of hypertension and chronic kidney disease. This novel proposal will investigate these specific aims: (1) to test the hypothesis that relaxin increases NO bioavailability during hypertension via increased NOS activity and reduced oxidative stress, (2) to determine if the renoprotective effects of relaxin are mediated by activation of endothelin type B (ETB) receptors, and (3) to determine if kidney specific upregulation of relaxin is antihypertensive and can prevent end organ damage. The candidate will use the work described in this proposal as the basis of an independent line of research into the role of relaxin in the prevention of chronic kidney disease, and a comprehensive training program has been designed to move the applicant to a career as an independent investigator. Dr. Chris Baylis, an exceptional renal physiologist and mentor, will serve as the candidate's mentor. Her expertise and the superb environment of the University of Florida, rich in clinical and basic sciences, will offer the candidate the best opportunity for achieving her goal of becoming an independent investigator in the field of renal physiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Cardiorenal Disease following Preeclampsia
-
批准号:9213459
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Jennifer M Sasser
-
依托单位:
Mechanisms of Renoprotection by Relaxin in Hypertension
-
批准号:8896778
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2012
-
负责人:Jennifer M Sasser
-
依托单位:
Mechanisms of Renoprotection by Relaxin in Hypertension
-
批准号:8487401
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2012
-
负责人:Jennifer M Sasser
-
依托单位:
Mechanisms of Renoprotection by Relaxin in Hypertension
-
批准号:9099826
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2012
-
负责人:Jennifer M Sasser
-
依托单位:
Mechanisms of Renoprotection by Relaxin in Hypertension
-
批准号:8280694
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2012
-
负责人:Jennifer M Sasser
-
依托单位:
海外基金